Malaria is one of the world’s leading killers, claiming the lives of over 250,000 children in Africa every year. Researchers have been trying for decades to come up with a viable solution to this global health problem, but haven’t made much progress. That is, until recently. This week, the world’s first malaria vaccine has begun a wide rollout, commencing in Malawi before being introduced into Ghana and Kenya over the following weeks. The RTS/S vaccine, currently the most advanced malaria vaccine in development, works by training the immune system to attack the malaria parasite, which is spread by mosquitos. The vaccine has been shown to prevent nearly 40 percent of malaria cases. While this isn’t an extraordinarily efficacious rate for a vaccine, it could still save thousands of lives in affected African areas. This initial pilot program is estimated to run until 2024, after which the results will be evaluated and broader implementation in other countries will be considered.
Pioneering malaria vaccine to roll out in Malawi
More of Today's Solutions
Why Western scientists are turning to Indigenous knowledge
BY THE OPTIMIST DAILY EDITORIAL TEAM Marco Hatch describes his own work with characteristic dry humor: "I'm a glorified clam counter." What he's actually ...
Read MoreThe science of why you keep falling for the same type of person
BY THE OPTIMIST DAILY EDITORIAL TEAM Most people have a type. Ask them to describe it and they will, with varying degrees of self-awareness: ...
Read MoreRepresentatives from 185 countries establish the Global Biodiversity Framewor...
Amid mounting worries about the health of our planet's ecosystems, delegates from 185 countries gathered on Thursday, August 24th in Vancouver, Canada, for the ...
Read MoreUK announces groundbreaking ‘Flee Funds’ scheme for domestic abus...
The UK Home Office is taking a significant step forward in the fight against domestic abuse by launching a £2 million (just over $2.5 ...
Read More
